Nivolumab combined with brentuximab vedotin with or without mediastinal radiotherapy for relapsed/refractory primary mediastinal large B-cell lymphoma

MeSH terms

• Adult
• Aged
• Antineoplastic Combined Chemotherapy Protocols* / therapeutic use
• Brentuximab Vedotin* / therapeutic use
• Female
• Humans
• Lymphoma, Large B-Cell, Diffuse* / drug therapy
• Lymphoma, Large B-Cell, Diffuse* / pathology
• Lymphoma, Large B-Cell, Diffuse* / radiotherapy
• Male
• Mediastinal Neoplasms* / drug therapy
• Mediastinal Neoplasms* / pathology
• Mediastinal Neoplasms* / radiotherapy
• Middle Aged
• Neoplasm Recurrence, Local / drug therapy
• Neoplasm Recurrence, Local / pathology
• Neoplasm Recurrence, Local / radiotherapy
• Nivolumab* / administration & dosage
• Nivolumab* / therapeutic use
• Treatment Outcome